Tag:
Alfacell
Latest Headlines
Latest Headlines
Alfacell stock takes a hit on Onconase data
New Jersey-based Alfacell took a major hit this morning as it announced that its drug Onconase missed the primary endpoint in a Phase III study. The drug failed to improve survival rates of patients
ALSO NOTED: Flamel shares buoyed by partnership buzz; Medarex cuts stake in Genmab; Bush offers new stem cell funds; and much m
> Shares of France's Flamel Technologies were buoyed by an analyst's prediction that the company was nearing a late-stage partnering deal.
